Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	26.18	32.18	25.51
Graham Fair Price	3.21	48.73	47.22
PEG	119.96	1.95	-0.89
Price/Book	17.55	2.28	1.94
Price/Cash Flow	-8.43	48.77	53.26
Prices/Earnings	9.35	14.23	13.01
Price/Sales	19.68	5.82	4.86
Price/FCF	-8.43	48.77	53.26
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.50	0.23	0.22
Operating Margin	19.40	0.12	0.10
ROA	7.28	0.02	0.02
ROE	0.04	0.04	7.50
ROIC	0.03	0.03	8.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.15	0.16	-2.64
Dividends QOQ	0.06	-0.01	-76.29
EBIT QOQ	-0.41	0.18	-57.58
EPS QOQ	-0.15	0.07	-50.28
FCF QOQ	-0.33	0.29	-11.83
Revenue QOQ	-0.11	-0.02	85.16
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.26	34.29	-2.74
Days Sales Outstanding (DSO)	41.88	45.18	7.87
Inventory Turnover	2.55	2.62	2.81
Debt/Capitalization	0.17	0.16	-2.06
Quick Ratio	1.07	1.02	-3.79
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	51.57	51.34	-0.46
Cash	7.95	8.34	4.93
Capex	-1.57	-1.27	19.08
Free Cash Flow	1.88	2.40	27.79
Revenue	20.57	20.11	-2.23
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.48	1.38	-6.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.00	0.48	-51.77
Naive Interpretation	Member

06 - Financial Health · Weak

Rating